New study says PrEP is just as safe as aspirin

A study published in the Oxford Journal’s Open Forum Infectious Diseases states that pre-exposure prophylaxis drugs are just as safe as the painkiller aspirin. While the effectiveness of PrEP for the prevention of HIV had been proven, doubts remained over possible side effects of the drug, including nausea and unintentional weight loss.

The study compared the effects to patients in 5 major research trials. According to the study: “PrEP for HIV infection favourably compares to aspirin in terms of user safety. While long-term studies are needed, providers should feel reassured about the safety of short- and medium-term PrEP for HIV infection with FTC-TDF.”   Read more via GayTimes